Researcher
Elisa Funck-Brentano
Persistent identifiers
References for this unit in public registries: they allow cross-checking with other sources and do not change when the name does.
Affiliation
Fields of expertise
dabrafenib
vemurafenib
trametinib
Immune Checkpoint Inhibitors
immune checkpoint inhibitor
CTLA-4
dacarbazine
adjuvant
10 publications in HAL since 2022.
Data provenance
Sources : scanR, HAL. Data compiled on 27/10/2026. Found an error? It is corrected in the original source (HAL, RNSR, directory); see how.